Charles River Laboratories International, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $123.4M | $154.8M | $149.3M | $126.7M | $102.8M | $97.9M | $110.0M | $-336.7M |
| Depreciation & Amortization | $131.2M | $126.7M | $94.9M | $96.4M | $96.6M | $81.3M | $85.2M | $93.6M |
| Depreciation | $89.8M | $85.0M | $70.7M | $70.5M | $78.8M | $63.2M | $63.4M | $69.2M |
| Amortization | $41.4M | $41.7M | $24.2M | $26.0M | $17.8M | $18.1M | $21.8M | $24.4M |
| Stock-Based Compensation | $44.0M | $43.6M | $40.1M | $31.0M | $24.5M | $21.9M | $21.7M | $25.5M |
| Net Cash from Operating Activities | $318.1M | $316.9M | $306.8M | $252.1M | $209.0M | $208.0M | $206.8M | $168.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $82.4M | $55.3M | $63.3M | $56.9M | $39.2M | $47.5M | $49.1M | $42.9M |
| Business Acquisitions | $25.0M | $648.5M | $247.7M | $234.3M | $29.2M | $16.9M | $0 | $0 |
| Net Cash from Investing Activities | $-72.6M | $-692.7M | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $106.9M | $12.3M | $117.5M | $122.0M | $165.9M | $64.2M | $283.8M | $356.5M |
| Net Cash from Financing Activities | $-208.5M | $380.8M | — | — | — | — | — | — |
| Net Change in Cash | $46.4M | $-321.0K | $-42.1M | $4.1M | $46.2M | $40.8M | $-110.3M | $-3.4M |
| Free Cash Flow | $235.6M | $261.6M | $243.6M | $195.2M | $169.9M | $160.5M | $157.7M | $125.4M |